Selective killing of candidate AML stem cells by antibody targeting of IL1RAP.

Research output: Contribution to journalArticle

Abstract

Key points IL1RAP is overexpressed on candidate AML stem cells and is a promising target for antibody-based therapy.

Details

Authors
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Hematology
Original languageEnglish
Pages (from-to)3709-3713
JournalBlood
Volume121
Issue number18
Publication statusPublished - 2013
Publication categoryResearch
Peer-reviewedYes